Depot leuprolide acetate dosage for sexual precocity

64Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Twenty-one children with early puberty have been evaluated to determine adequate dosage of depot leuprolide acetate. The minimal dosage of depot leuprolide acetate required, using intervals of 1.5 mg or less when given every 28 days, was determined. This dosage, as determined by suppression of gonadotropin responses to GnRH stimulation, was 4.14 ± 1.33 mg (mean ± SD) and 0.15 ± 0.07 mg/kg·28 days. The dosage correlates with bone age and pubertal stage and is larger among patients with more advanced puberty. Five patients required a larger dosage from 5-10 months after initial suppression. Therefore, to monitor suppression, GnRH testing should be repeated at least at 6-month intervals. Samples 20 and 40 min after GnRH stimulation are sufficient to indicate adequacy of treatment, so an abbreviated test could be used.

Cite

CITATION STYLE

APA

Parker, K. L., Baens-Bailon, R. G., & Lee, P. A. (1991). Depot leuprolide acetate dosage for sexual precocity. Journal of Clinical Endocrinology and Metabolism, 73(1), 50–52. https://doi.org/10.1210/jcem-73-1-50

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free